Sage Therapeutics, Inc. Operating Lease Right-of-Use Assets
Sage Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $9.96 million as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-07-30
- 2025-06-30: Operating Lease, Right-of-Use Asset $9.96M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $10.36M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $10.75M.
- 2024-09-30: Operating Lease, Right-of-Use Asset $11.25M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-06-30 | $9.96M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $10.36M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $10.75M 10-Q · filed 2025-07-30 | |
| 2024-09-30 | $11.25M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $1.22M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $2.86M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $4.46M 10-K · filed 2025-02-11 | |
| 2023-09-30 | $6.03M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $7.56M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $9.06M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $10.53M 10-K · filed 2024-02-14 | |
| 2022-09-30 | $11.97M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $13.38M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $14.76M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $16.11M 10-K · filed 2023-02-16 | |
| 2021-12-13 | $3.70M 10-K · filed 2024-02-14 | $3.70K 10-K · filed 2022-02-24 |
| 2021-09-30 | $17.43M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $18.73M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $3.70M 10-Q · filed 2022-11-08 | $20.00M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $25.06M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $26.55M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $28.00M 10-Q · filed 2020-08-10 | |
| 2020-05-31 | $2.30M 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $31.99M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $33.77M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $35.51M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $37.22M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $38.12M 10-Q · filed 2019-05-02 | |
| 2019-01-01 | $5.30M 10-K · filed 2023-02-16 | $41.10M 10-Q · filed 2019-05-02 |